stella
beta
Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients. — Stella
Recruiting
Back to Β-thalassemia trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(3 sites)
China
Guangxi Medical University First Affiliated Hospital, Guangxi
Shenzhen Children's Hospital, Shenzhen
Shenzhen University General Hospital, Shenzhen
View full record on ClinicalTrials.gov